[1] KATO H,NAKAJIMA M.Treatments for esophageal cancer:a review[J].Gen Thorac Cardiovasc Surg,2013,61(6):330-335.
[2] LORDICK F,HOLSCHER A H,HAUSTERMANS K,et al.Multimodal treatment of esophageal cancer[J].Langenbecks Arch Surg,2013,398(2):177-187.
[3] HAISLEY K R,HART K D,NABAVIZADEH N,et al.Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer[J].Dis Esophagus,2017,30(7):1-7.
[4] ZHU Z Q,ZHU Z A,CAI H X.Continuous infusion of a large dose of CF(folinic acid) and 5-FU combined with CDDP in the treatment of advanced esophageal cancer[J].Int J Clin Pharmacol Ther,2017,55(5):397-402.
[5] HAMAGUCHI T,SHIMADA Y,MIZUSAWA J,et al.Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage Ⅲ colorectal cancer(JCOG0910):an open-label non-inferiority randomized phase 3 multicentre trial[J].Lancet Gastroenterol Hepatol,2018,3(1):47-56.
[6] ELAMIN Y Y,RAFEE S,OSMAN N,et al.Thymidine phosphorylase in cancer:enemy or friend[J].Cancer Microenviron,2016,9(1):33-43.
[7] KOBUCHI S,YAZAKI Y,ITO Y,et al.Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats[J].Eur J Pharm Sci,2018,112:152-158.
[8] TOI M,MASUDA N,LEE S J.Capecitabine for primary breast cancer[J].Oncotarget,2017,8(67):110739-110740.
[9] KU G Y.Systemic therapy for esophageal cancer:chemotherapy[J].Chin Clin Oncol,2017,6(5):49.
[10] WAGNER A D,SYN N L,MOEHLER M,et al.Chemotherapy for advanced gastric cancer[J].Cochrane Database Syst Rev,2017,8:CD004064.
[11] SCHWARTZ L H,LITIÈRE S,DE VRIES E,et al.RECIST 1.1-Update and clarification:From the RECIST committee[J].Eur J Cancer,2016,62:132-137.
[12] FULTON B A,GRAY J,MCDONALD A,et al.Single centre outcomes from definitive chemo-radiotherapy and single modality radiotherapy for lacally advanced oesophageal cancer[J].J Gastrointest Oncol,2016,7(2):166-172.
[13] NAKAJIMA Y,KAWADA K,TOKAIRIN Y,et al.Salvage chemoradiotherapy for locally advanced esophageal carcinomas[J].Dis Esophagus,2015,28(5):460-467.
[14] KUMABE A,ZENDA S,MOTEGI A,et al.Long-term clinical results of concurrent chemoradiotherapy for patients with cervical esophageal squamous cell carcinoma[J].Anticancer Res,2017,37(9):5039-5044.
[15] MOFID B,RAZZAGHDOUST A,KASHI A S,et al.A comparative study of cisplatin-based definitive chemo-radiation in non-metastatic squamous cell carcinoma of the esophagus[J].Electron Physician,2016,8(10):3069-3075.
[16] KWSKMAN J J,PUNT C J.Oral drugs in the treatment of metastatic colorectal cancer[J].Expert Opin Pharmacother,2016,17(10):1351-1361.
[17] GUO Y,XIONG B H,ZHANG T,et al.XELOX vs. FOLFOX in metastatic colorectal cancer:An updated meta-analysis[J].Cancer Invest,2016,34(2):94-104.
[18] IQBAL H,PAN Q.Capecitabine for treating head and neck cancer[J].Expert Opin Investig Drugs,2016,25(7):851-859. |